0000899243-21-021198.txt : 20210528
0000899243-21-021198.hdr.sgml : 20210528
20210528192948
ACCESSION NUMBER: 0000899243-21-021198
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210514
FILED AS OF DATE: 20210528
DATE AS OF CHANGE: 20210528
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parkinson Paul
CENTRAL INDEX KEY: 0001826133
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26642
FILM NUMBER: 21982353
MAIL ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MYRIAD GENETICS INC
CENTRAL INDEX KEY: 0000899923
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 870494517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
BUSINESS PHONE: 801-584-3600
MAIL ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-05-14
1
0000899923
MYRIAD GENETICS INC
MYGN
0001826133
Parkinson Paul
320 WAKARA WAY
SALT LAKE CITY
UT
84108
0
1
0
0
Fmr EVP Strategy & Innovation
Common Stock
87407
D
This "Exit" Form 4 is voluntarily filed to report solely that the Reporting Person is no longer serving as the Company's EVP Strategy and Innovation, effective as of May 14, 2021, and therefore is no longer subject to Section 16 reporting.
By: Nathan A. Smith For: Paul Parkinson
2021-05-28